Why is it said that the first FDA certification of this expensive blood glucose monitoring device brings hope to the industry?
|
Recently, Medtronic's MiniMed 670G has suddenly dominated the news of major health wearable media. It has recently passed FDA certification and will be available next summer. MiniMed 670G is the world's first continuous blood glucose meter that can inject insulin into the body. It uses an algorithm called "SmartGuard HCL" to determine blood glucose concentration and automatically inject insulin at the right time. In July, Medtronic had already conducted a small-scale test under FDA supervision, and the feedback was good. Leifeng.com also followed up on this. In addition to Medtronic, the Juvenile Diabetes Research Foundation (JDRF) also participated in the development of the product, believing that it will play an important role in the control of type 1 diabetes. "This product is a breakthrough and has been approved by the FDA," said Derek Rapp, chairman and CEO of JDRF. "We are very proud of our contribution to the development of this product and we will work with Medtronic to ensure that patients' diabetes management is maintained." When talking about this with Yang Feng, CEO of Jianan Huaxia, which focuses on diabetes management, it is not difficult to feel his excitement from his tone. In his opinion, this is something that makes "the industry excited." "First of all, from a legal perspective, MiniMed 670G has set a precedent and become the first intelligent product in this field in the world to pass FDA certification. Generally speaking, a country will be extremely cautious and careful in verifying the first product. Now that it has passed, it shows that the country recognizes the direction of intelligence." It is worth mentioning that MiniMed 670G is a blood sugar product designed for type 1 diabetes, which also determines that its audience range will be relatively small. Type 1 diabetes, also known as insulin-dependent diabetes, usually refers to insulin deficiency caused by genetic factors or autoimmune system defects, and often occurs in children and adolescents. According to Yang Feng, type 1 diabetes patients account for 10% of all diabetics abroad, but only 5% in China, and the ratio of injections to pumps is about 10:1. Take China as an example. Even if it has passed the domestic medical clinical trials, there may be less than five patients out of a thousand who can actually use the hanging pump method, not to mention the automatic hanging pump. This means that the MiniMed 670G is destined to have a smaller audience than expected due to its limited user population. In addition, many people believe that the device's price of $799 may be a considerable expense. This comment at the bottom of digitaltrend is a good example. Leifeng.com editor translated it and excerpted it here: This netizen named Thomas Kimball made an account with the author Bruce Brown: I am a type 1 diabetic, and I have been diagnosed for 23 years. It is great to be able to control blood sugar in real time, but it is too expensive. If I want to use this product smoothly, I have to spend about $1,200 per month, plus $800 for insulin injections, and about $250 for pump tubing. Yang Feng also told Leifeng.com that the price of the equipment is actually just a drop in the bucket for consumables. The reason why the price of consumables cannot be reduced is the current technology monopoly. "Injection tubes generally need to be replaced every three to seven days. If we calculate it at 900 yuan a week, it is a considerable expense a month. The reason for this high expense is that the technical barriers of the tubes are very high. The liquid in the tube cannot adhere to the wall or crystallize. In addition, the tube must be UV-proof, otherwise the quality of the insulin will change due to radiation." Leifeng.com (search "Leifeng.com" WeChat account to follow) learned that this technology is currently mainly concentrated in several European manufacturers. There are also domestic manufacturers working on it, but the technology has not yet reached the corresponding standards, resulting in high product prices. The monopoly of technology has led to a situation where there are too many people and too little food, so it is no wonder that the price is so unaffordable, and the audience of the product has naturally decreased by half. If MiniMed 670G is to be used smoothly in China, it still has to overcome the restrictions of policies and medical insurance. The US medical insurance system may still help patients overcome the problem of expensive consumables, but it is unlikely to be realized in China at present. "If the country can provide more support for medical insurance, more patients can get real benefits." As a major focus of Internet + medical care, if the outpatient management of chronic diseases can be benefited from medical insurance, it will also play a role in alleviating the national contradiction of "difficulty in seeing a doctor". Although MiniMed 670G may not be widely used among diabetics for a while due to factors such as cost and technology, we cannot deny that Medtronic has obtained legal approval from the FDA, which shows that the general direction is correct. With the trial of this product by Medtronic, the progress of subsequent blood glucose products in the review and development will be accelerated a lot, which can be said to be a shot in the arm for the entire industry. In addition, if manufacturers can start from another direction and use technical means to reduce the cost of pump tubes, it will also promote the popularization of intelligent blood glucose meters. Blood sugar products have evolved from pure monitoring to the "monitoring + treatment" link, and have been supported and recognized by the law. With the demonstration of MiniMed 670G, more intelligent blood sugar control products will surely pass qualification certification in the future and benefit more diabetics. As a winner of Toutiao's Qingyun Plan and Baijiahao's Bai+ Plan, the 2019 Baidu Digital Author of the Year, the Baijiahao's Most Popular Author in the Technology Field, the 2019 Sogou Technology and Culture Author, and the 2021 Baijiahao Quarterly Influential Creator, he has won many awards, including the 2013 Sohu Best Industry Media Person, the 2015 China New Media Entrepreneurship Competition Beijing Third Place, the 2015 Guangmang Experience Award, the 2015 China New Media Entrepreneurship Competition Finals Third Place, and the 2018 Baidu Dynamic Annual Powerful Celebrity. |
<<: Will Android devices and iPhones support Windows 10's "killer app"?
>>: Apple Watch 2 first review: sports features revealed
Recommend
[Tutorial] How did a 16-year-old hacker install Windows 95 on a smartwatch?
Corbin Davenport, a 16-year-old hacker from Georg...
WebGL tutorial "WebGL Basics Practical Video" teaching
Training course video lecture content introductio...
How to pay social security during the epidemic? How do units and individuals pay respectively?
The social security exemption policy was introduc...
Using special chocolate as material! He spent 9 years making edible 3D printing
"3D printing is something you can never fini...
There are many benefits to being hungry! Not only does it help you lose weight, it also helps you live longer!
"Don't let yourself go hungry!" Thi...
Lucheng SEO training: Several common black hat methods
In the SEO industry, the only thing that does not...
The latest list of sealed-off communities in Shenyang in 2022: Which specific communities need to be quarantined? Attached is the latest news!
Recently, new cases have appeared in some areas o...
Who are the Chinese “old residents” on the far side of the moon?
Since the impact craters on the back side of the ...
QQ account hacked, 7.09 million yuan lost
On May 4 this year, a company in Duanzhou, Zhaoqi...
Apple releases first artificial intelligence report: new image recognition
Apple has finally stopped hiding and released its ...
The dead bird was reborn as a drone, and will fly with the flock of birds. I wonder if other birds can find out that it died a long time ago...
The dead bird flapped its wings again and soared ...
Sony PS VR experience: comfortable to wear, but the controller is terrible
Although this is not the first time we have seen ...
The eighth period of the periodic table is about to be opened, and physicists are "creating" superheavy elements!
[Mobile software: Bo Ke Yuan] Physicists' mea...
Dabin's "Short Video Editing Operation Tutorial" 0 basic teaching seven days to get started to master
Dabin's "Short Video Editing Operation T...